MHC association with response to infliximab therapy in rheumatoid arthritis patients.

被引:0
|
作者
Fernandez-Gutierrez, B
Martinez, A
Salido, M
Bonilla, G
Pascual-Salcedo, D
de la Concha, EG
机构
[1] Hosp Clin San Carlos, Madrid, Spain
[2] Hosp Univ La Paz, Madrid, Spain
来源
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
223
引用
收藏
页码:S128 / S128
页数:1
相关论文
共 50 条
  • [41] Positive effects of infliximab therapy on bone metabolism in patients with rheumatoid arthritis.
    Thomas, T
    Garnero, P
    le Henanff, A
    Debiais, F
    Le Loet, X
    Roux, C
    Sany, J
    Wendling, D
    Zarnitsky, C
    Ravaux, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S333 - S333
  • [42] Influence of 677 (C/T) and 1298 (A/C) MTHFR polymorphisms on the response to infliximab therapy in rheumatoid arthritis patients
    Sainz, J
    Cáliz, R
    Martin, J
    Pérez, MJ
    Ferrer, MA
    Garcia, A
    Rodriguez, C
    Collado, MD
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 122 - 122
  • [43] Infliximab therapy partially improves lipid profile in patients with refractory rheumatoid arthritis
    Allanore, Y
    Borderie, D
    Sellam, J
    Ekindjian, O
    Kahan, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 261 - 261
  • [44] Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
    Voulgari, Paraskevi V.
    Alamanos, Yannis
    Drosos, Alexandros A.
    CURRENT CLINICAL PHARMACOLOGY, 2006, 1 (01): : 103 - 108
  • [45] Use of in-office MRI in the evaluation of patients with rheumatoid arthritis on infliximab therapy
    Gaylis, N
    Needell, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 182 - 182
  • [46] Cost effectiveness analysis of etanercept (ENBREL) versus infliximab (Remicade) in the treatment of rheumatoid arthritis patients.
    Malone, DC
    Ortmeier, BG
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S95 - S95
  • [47] Infliximab induced hipus in patients with rheumatoid arthritis
    Elkayam, O
    Caspi, D
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (04) : 502 - 503
  • [48] Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients
    Rinaudo-Gaujous, Melanie
    Blasco-Baque, Vincent
    Miossec, Pierre
    Gaudin, Philippe
    Farge, Pierre
    Roblin, Xavier
    Thomas, Thierry
    Paul, Stephane
    Marotte, Hubert
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (05)
  • [49] Dose intensification with infliximab in patients with rheumatoid arthritis
    Berger, A
    Edelsberg, J
    Li, TT
    Maclean, JR
    Oster, G
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (12) : 2021 - 2025
  • [50] ADAMTS5 Is a Biomarker for Prediction of Response to Infliximab in Patients with Rheumatoid Arthritis
    Tsuzaka, Kensei
    Itami, Yuka
    Takeuchi, Tsutomu
    Shinozaki, Naoshi
    Morishita, Tetsuo
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1454 - 1460